Cocrystal Pharma (COCP) Depreciation & Amortization - Total (2010 - 2011)
Cocrystal Pharma's (COCP) quarterly Depreciation & Amortization - Total came in at $205352.0 in Q3 2011, up 133.71% year-over-year from $87867.0 in Q3 2010, and up 133.71% quarter-over-quarter from $87867.0 in Q3 2010.
Powered by 
Analysis
Cocrystal Pharma (COCP) Depreciation & Amortization - Total (2010 - 2011) Analysis & Trends
Cocrystal Pharma has disclosed Depreciation & Amortization - Total across 2 years of filings, most recently posting $205352.0 for Q3 2011.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Tot) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | - |
| 10 | Cocrystal Pharma | 16.82 Mn | 14.50 Mn | - | - |